Collectively, these prediction-based analyses are consistent with the possibility that both SPO and EPO may be linked to a shared network related to inflammation, oxidative stress, and cancer-associated signaling, and nominate NOS2 (iNOS) as a common putative candidate target that warrants further experimental validation. Here, EPO is linked to cancer.